Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Dance With Domestic Companies: Pfizer And Merck Look To Broaden Market Access In China Via JVs

This article was originally published in The Pink Sheet Daily

Executive Summary

Merck/Simcere, Pfizer/Hisun launched JVs in China this week to increase sales in outlying cities.


Related Content

Merck And Simcere Trial Partnership In China: Two Different Cultures But One Common Goal
China's Price Cuts And Antibiotic Limits Weigh On Simcere, But Merck JV Opens Doors
Pfizer China Country Manager Wu Xiaobing And General Manager For Commercial And Diversified Business Kevin Xiao On Expansion To Rural Markets In China: An Interview With PharmAsia News
China's New Drug Price Policies Will Favor Big Distributors, Restrict Smaller Ones
China's Essential Drug Prices Less Severe Than Expected; Some Prices See Increases


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts